Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Retail Industry News CarMax surges about 10% on a fiscal first quarter double beat, aided by a short squeeze CarMax (KMX) surges about 10 percent on a fiscal Q1 double beat and resilient comps, aided by a short squeeze, though margins remain pressured. Full analysis. bySrinathJune 19, 2026